Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma × Vemurafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 24 Neoplasms 9 Neoplasm Metastasis 5 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Skin Neoplasms 2 Thyroid cancer, follicular 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Solid Tumor 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Noonan syndrome 3 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1

Interventions

Rituximab 53 Cyclophosphamide 53 fludarabine 35 fludarabine phosphate 29 Filgrastim 25 Etoposide 20 Melphalan 19 Gemcitabine 17 Bendamustine Hydrochloride 17 Vincristine 15 Cytarabine 15 Peripheral Blood Stem Cell Transplantation 14 Bortezomib 14 pembrolizumab 13 aldesleukin 13 Prednisone 13 Doxorubicin 12 Sirolimus 11 Busulfan 11 obinutuzumab 10 Whole-Body Irradiation 10 Vorinostat 10 Lenalidomide 10 Dexamethasone 10 Tacrolimus 9 sargramostim 8 romidepsin 8 Radiotherapy 8 Paclitaxel 8 Nivolumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636622 2020-06-18

Study of Vemurafenib, Carboplatin, and Paclitaxel

M.D. Anderson Cancer Center

Phase 1 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡